Skip to main content
European Commission logo
Enterprise Europe Network

A French SME develops and produces in vitro rapid tests on demand and seeks partners needing new rapid tests developments

Summary

Profile Type
  • Technology offer
POD Reference
TOFR20230327032
Term of Validity
26 May 2023 - 25 May 2025
Company's Country
  • France
Type of partnership
  • Research and development cooperation agreement
Targeted Countries
  • All countries
Contact the EEN partner nearest to you for more information.
Find my local partner

General information

Short Summary
A French SME develops and produces in vitro rapid tests and brings projects from the proof of concept to large scale production using automated production lines. It is looking for companies in need of new rapid tests developments using lateral flow immunoassay technique.
Full Description
A French SME develops and produces in vitro rapid tests. Based on over 20 years of experience in the field of immunological techniques and biomarkers detection, the compliant ISO 13485 french SME develops rapid tests and brings projects from the proof of concept to large scale production using automated production lines. Moreover, the SME has integration capacities for e-Health using connected readers and software applications on demand.
The SME is looking for different kinds of partners:
1) Companies have needs in R&D in the field of new rapid tests developments. These rapid tests using lateral flow immunology techniques have a broad field of applications. Therefore, the SME can develop for these companies rapid tests (qualitative or quantitative) for biomarkers, contaminant or frauds detection in many domains (health, agriculture, food industry...).
2) Companies having needs for large scale rapid tests production. The SME has set-up automated production lines and is be able to produce up to 1 million rapid tests per month upon request.
Advantages and Innovations
Large scale production
Design and development of new tests
Stage of Development
  • Already on the market
Sustainable Development Goals
  • Goal 3: Good Health and Well-being
  • Goal 9: Industry, Innovation and Infrastructure
IPR status
  • IPR granted

Partner Sought

Expected Role of a Partner
The SME is looking for different kinds of partners:
1) Companies have needs in R&D in the field of new rapid tests developments. These rapid tests using lateral flow immunology techniques have a broad field of applications. Therefore, the SME can develop for these companies rapid tests (qualitative or quantitative) for biomarkers, contaminant or frauds detection in many domains (health, agriculture, food industry...).
2) Companies having needs for large scale rapid tests production. The SME has set-up automated production lines and is be able to produce up to 1 million rapid tests per month upon request.
Type and Size of Partner
  • SME 50 - 249
  • Other
  • SME <=10
  • Big company
  • SME 11-49
Type of partnership
  • Research and development cooperation agreement

Dissemination

Technology keywords
  • 06002007 - In vitro Testing, Trials
  • 06002002 - Cellular and Molecular Biology
  • 06002009 - Molecular design
  • 06005004 - Remote diagnostics
Market keywords
  • 05001002 - In-vitro diagnostics
  • 005001008 - Diagnostic test products and equipment
Sector Groups Involved
  • Health
  • Agri-Food
Targeted countries
  • All countries